

HY-P991214 · 1 mg
MedChemExpress · Cat: HY-P991214
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/tucotuzumab-celmoleukin.htmlDescription
Tucotuzumab celmoleukin EMD 273066 is an immunocytokine fusion agent targeting the epithelial cell adhesion molecule EpCAM . Tucotuzumab celmoleukin binds to EpCAM and delivers IL-2 to the tumor microenvironment, which can activate cytotoxic effector cells, such as CD8+ T cells and natural killer NK cells. Tucotuzumab celmoleukin is promising for research of EpCAM-positive cancers, such as colorectal cancer and prostate cancer.







